<table><tr><th>Template</th><th>Technical</th></tr><tr><td>10.5.1.1: Statistical Analysis Method 3</td><td>Amendment Details: Amendment Scope Enrolment Description</td></tr><tr><td>10.5.1.4: Sensitivity Analysis 4</td><td>1.1.2: Sponsors Investigational Product Codes 4</td></tr><tr><td>10.5.1.5: Supplementary Analysis 5</td><td>1.1.2: NonProprietary Names</td></tr><tr><td>12.2: Country-Region Identifier</td><td>1.1.2: Enter Not applicable</td></tr><tr><td>12.3: - or - enrolled globally-locally-per cohort</td><td>1.1.2: Nonproprietary name 5</td></tr><tr><td>12.3: Sponsor Approval Date 7</td><td>1.1.2: INN 6</td></tr><tr><td>12.3: enter amendment number</td><td>3.1.X: X is a unique number for each primary objective: Table of Estimand Characteristics including Endpoint at a minimum</td></tr><tr><td>12.3: enter date</td><td>3.2.X: Secondary Objective X</td></tr><tr><td>12.3: Description of Change 8</td><td>3.2.X: Enter Table of Estimand Characteristics including Endpoint at a minimum</td></tr><tr><td>12.3: Brief Rationale for Change 9</td><td>3.2.X: Population 7</td></tr><tr><td>12.3: Section - and Name of Change 10</td><td>3.2.X: Treatment 8</td></tr><tr><td>12.3: Description of Change 11</td><td>3.2.X: Endpoint 9</td></tr><tr><td>12.3: Brief Rationale for Change 12</td><td>3.2.X: Population-Level Summary 10</td></tr><tr><td>12.3: Section - and Name of Change 13</td><td>3.2.X: Intercurrent Event Strategy</td></tr><tr><td>: </td><td>3.3.X: Enter Table of Estimand Characteristics</td></tr><tr><td>: </td><td>3.3.X: Population 11</td></tr><tr><td>: </td><td>3.3.X: Treatment 12</td></tr><tr><td>: </td><td>3.3.X: Endpoint 13</td></tr><tr><td>: </td><td>3.3.X: Population-Level Summary 14</td></tr><tr><td>: </td><td>3.3.X: Description of Intercurrent Event 15</td></tr><tr><td>: </td><td>3.3.X: Intercurrent Event - Strategy</td></tr><tr><td>: </td><td>5.1: Prospective approval of protocol deviations to recruitment and enrollment criteria also known as protocol waivers or exemptions is not permitted</td></tr><tr><td>: </td><td>5.2: To be eligible to participate in this trial an individual must meet all the following criteria</td></tr><tr><td>: </td><td>5.2: -</td></tr><tr><td>: </td><td>5.2: Inclusion Criterion</td></tr><tr><td>: </td><td>5.3: An individual who meets any of the following criteria will be excluded from participation in this trial</td></tr><tr><td>: </td><td>5.3: - 16</td></tr><tr><td>: </td><td>5.3: Exclusion Criterion</td></tr><tr><td>: </td><td>6.1: Additional Text if Needed</td></tr><tr><td>: </td><td>9.2.4: Adverse Events of Special Interest or state Not applicable</td></tr><tr><td>: </td><td>10.5.X.1: Statistical Method of Analysis 17</td></tr><tr><td>: </td><td>10.5.X.4: Sensitivity Analysis 18</td></tr><tr><td>: </td><td>10.5.X.5: Supplementary Analysis 19</td></tr><tr><td>: </td><td>12.2: Not applicable 20</td></tr><tr><td>: </td><td>12.3: Prior Protocol Amendments</td></tr><tr><td>: </td><td>12.3: - or -</td></tr><tr><td>: </td><td>12.3: globally-locally-per cohort</td></tr><tr><td>: </td><td>Amendment Details: - or - 22</td></tr><tr><td>: </td><td>12.3: amendment number</td></tr><tr><td>: </td><td>12.3: Sponsor Approval Date 23</td></tr><tr><td>: </td><td>12.3: Description of Change 24</td></tr><tr><td>: </td><td>12.3: Brief Rationale for Change 25</td></tr><tr><td>: </td><td>12.3: Section - and Name of Change 26</td></tr><tr><td>: </td><td>12 X
where X is a unique number for each Additional Appendix: Enter Appendix</td></tr></table>